T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3+Th2 phenotype

[1]  S. Kummerfeld,et al.  Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes , 2019, Cell reports.

[2]  K. Tarte,et al.  Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology , 2019, Proceedings of the National Academy of Sciences.

[3]  S. Raychaudhuri,et al.  Distinct fibroblast subsets drive inflammation and damage in arthritis , 2019, Nature.

[4]  G. Schett,et al.  Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis , 2018, Nature Reviews Rheumatology.

[5]  J. Smolen,et al.  Diagnosis and Management of Rheumatoid Arthritis: A Review , 2018, JAMA.

[6]  E. Theander,et al.  Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients , 2018, Arthritis Research & Therapy.

[7]  N. Hacohen,et al.  Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry , 2018, bioRxiv.

[8]  Nir Hacohen,et al.  Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis , 2018, Nature Communications.

[9]  R. Darnell,et al.  Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation , 2018, Nature Communications.

[10]  P. Tak,et al.  Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis , 2017, PloS one.

[11]  Hong-Hee Kim,et al.  Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis , 2017, Arthritis Research & Therapy.

[12]  G. Firestein,et al.  Immunopathogenesis of Rheumatoid Arthritis. , 2017, Immunity.

[13]  E. Theander,et al.  Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker , 2017, Arthritis Research & Therapy.

[14]  Kamil Slowikowski,et al.  Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis , 2017, Nature.

[15]  A. Rudin,et al.  Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects , 2016, Journal of leukocyte biology.

[16]  J. Gaughan,et al.  Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study , 2016, Arthritis Research & Therapy.

[17]  E. Lubberts,et al.  CCR6+ Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[18]  H. Ueno,et al.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. , 2011, Immunity.

[19]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[20]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[21]  J. Rocklöv,et al.  Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[22]  C. Gordon,et al.  Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin , 2005, Arthritis research & therapy.

[23]  P. McIntyre,et al.  Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability. , 1999, The American journal of pathology.

[24]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[25]  S. Bang,et al.  Update on the genetic architecture of rheumatoid arthritis , 2017, Nature Reviews Rheumatology.

[26]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[27]  D. Patel,et al.  CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. , 2001, Clinical immunology.